ofloxacin has been researched along with vancomycin in 129 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (8.53) | 18.7374 |
| 1990's | 30 (23.26) | 18.2507 |
| 2000's | 56 (43.41) | 29.6817 |
| 2010's | 28 (21.71) | 24.3611 |
| 2020's | 4 (3.10) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Aghatabay, NM; Dülger, B; Haciu, D; Karabiyik, T; Neshat, A; Somer, M | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Aghatabay, NM; Dulger, B; Gucin, F; Senel, M; Somer, M | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Aghatabay, NM; Cevik, H; Dulger, B; Mahmiani, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Aghatabay, NM; Baş, A; Dülger, B; Gücin, F; Kircali, A; Sen, G; Yazicioğlu, MB | 1 |
| Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Aytemir, MD; Ozçelik, B | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Awang, K; Bignon, J; Blanchard, F; Butel, MJ; Cachet, X; Corlay, N; Leborgne, E; Lecsö-Bornet, M; Litaudon, M; Roussi, F | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Huo, L; Liu, H; Qiu, SX; Tan, H; Wang, M; Xu, Z; Yang, B; Zhang, W; Zhao, L | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Lei, M; Lu, X; Tang, W; Wu, C; Xie, Y; Zha, L; Zhang, J | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Mochizuki, K; Torisaki, M; Wakabayashi, K | 1 |
| Chan, CY; Cheng, IK; Wong, WT | 1 |
| Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
| Albrecht, LM; Barriere, SL; Kaatz, GW; Rybak, MJ; Seo, SM | 1 |
| Akalin, HE; Baykal, M | 1 |
| Mochizuki, K; Sasaki, T; Shirao, Y; Torisaki, M; Yamashita, Y | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
| Breyer, S; Georgopoulos, A; Hirschl, AM; Rotter, ML; Stanek, G | 1 |
| Hausmann, L; Tacke, W | 1 |
| Fernández-Roblas, R; Ponte, C; Santamaría, M; Soriano, F; Torres, A | 1 |
| Boussougant, Y; Carbon, C; Dutoit, C; Ichou, F; Weber, P | 1 |
| Carlstedt-Duke, B; Høverstad, T; Lingaas, E; Midtvedt, T; Norin, KE; Saxerholt, H; Steinbakk, M | 1 |
| Hryniewicz, W; Trzciński, K; Tyski, S; Zareba, T | 1 |
| Kaiser, AB; Kernodle, DS | 1 |
| Brook, I; Ledney, GD; Tom, SP | 1 |
| Khardori, N; Wilson, K; Yassien, M | 1 |
| Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
| Arai, T; Kinoshita, T; Nimura, N | 1 |
| Eliopoulos, GM; Moellering, RC; Wennersten, CB | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Palmer, SM; Rybak, MJ | 1 |
| Hanberger, H; Nilsson, LE; Svensson, E | 1 |
| Bryskier, A; Capper, T; Klugman, KP | 1 |
| Aikawa, N; Denno, R; Fujimoto, M; Hirata, AK; Ishibiki, K; Ishihara, R; Ishikawa, S; Iwai, S; Kinoshita, H; Koide, H; Kunimatsu, M; Manabe, T; Mashita, K; Mizuno, A; Morimoto, K; Mukaiya, M; Ohnishi, H; Ohtsuka, K; Sakaguchi, S; Shinagawa, N; Takuma, K; Tanimura, H; Umemoto, Y; Ushijima, Y; Yura, J | 1 |
| Andriole, VT; Dembry, LM; Farrel, PA; Gerrity, LA; Orcutt, DR | 1 |
| Botek, R; Grausova, S; Grey, E; Koren, P; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Lacka, J; Oravcova, E; Rusnakova, V; Sorkovska, D; Spanik, S; Stopkova, K; Studena, M; Svec, J; Trupl, J | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
| Tuohy, M; Washington, JA | 1 |
| Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
| Hamer, KE; Rupp, ME | 1 |
| Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
| Kang-Birken, SL | 1 |
| Azimi, PH; Brenner, RA; Clark, P; Clemens, J; Gill, V; Lin, FY; Philips, JB; Pratt, E; Regan, J; Rhoads, GG; Troendle, J; Weisman, LE | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Forest, G; Henry, M; Oldach, D; Simsir, A | 1 |
| Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L | 1 |
| Georgopoulos, A; Graninger, W; Grisold, A; Mueller-Uri, P; Presterl, E | 1 |
| Bisognano, C; Francois, P; Lew, DP; Schrenzel, J; Vaudaux, P | 1 |
| Baptista, MI; Da Cunha, CA; Kondo, W; Martins, LT; Rocha, JL | 1 |
| Akasaki, M; Blosser-Middleton, RS; Critchley, IA; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yamakita, J | 1 |
| Fujita, A; Inagaki, K; Inatomi, T; Kinoshita, S; Koizumi, N; Sano, Y; Sotozono, C | 1 |
| Biser, S; Donnenfeld, ED; Perry, HD; Solomon, R | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Matoba, AY | 1 |
| Safdar, A | 1 |
| Appelbaum, PC; Bozdogan, B; Chaitram, J; Clark, N; Jevitt, L; Killgore, G; McAllister, S; McDougal, LK; O'Hara, CM; Patel, JB; Tenover, FC; Weigel, LM | 1 |
| Akins, RL; Cha, R; Rybak, MJ | 1 |
| Cicek-Senturk, G; Erdem, I; Karagul, E; Yucesoy-Dede, B; Yuksel, S; Yuksel-Kocdogan, F | 1 |
| Shiotani, J; Takehana, K | 1 |
| Leaders, CB; Peters, L; Wall, GC; Wille, JA | 1 |
| Brian, SR; Kimbrough, RC | 1 |
| Alió, JL; Ferrer, C; Montero, J; Rodríguez, A; Ruiz-Moreno, JM | 1 |
| Arnold, FW; Wojda, B | 1 |
| Caniça, M; Dias, R; Louro, D | 1 |
| Barberá Farré, JR; Carranza González, R; Fernández Cenjor, J; Prieto Gómez, E; Tena Gómez, D | 1 |
| Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F | 1 |
| Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
| Donnenfeld, ED; Ehrenhaus, M; Maloney, RK; Manche, EE; Matzkin, DC; Moshirfar, M; Mozayeni, RM; Perry, HD; Rubinfeld, RS; Solomon, KD; Solomon, R; Wittpenn, JR | 1 |
| Decker, BS; Mueller, BA; Sowinski, KM | 1 |
| Hassoun, A; Ibrahim, F | 1 |
| Barralet, JE; Gbureck, U; Müller, FA; Vorndran, E | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| Howell, JM; Mohammadi, A | 1 |
| Abad, JL; Alió, JL; Fernandez, J; Ferrer, C; Rodríguez, A | 1 |
| Adolph, E; Aepinus, C; Petzsch, M; Podbielski, A; von Eiff, C | 1 |
| Gutiérrez, F; Hernández, I; Masiá, M; Matoses, C; Murcia, A; Navarro, A; Padilla, S; Romero, I; Sánchez, V | 1 |
| Abe, H; Arakawa, Y; Fujikawa, H; Ishigami, T; Matsuoka, S; Miyagawa, M; Moriyama, M; Ryuzaki, H | 1 |
| Lau, SK; Woo, PC; Yuen, KY | 1 |
| Alqahtani, M; Ciccotelli, W; Cox, P; Low, D; Morris, S; Opavsky, M; Pillai, D; Poutanen, S | 1 |
| Li, R; Liu, C; Sun, XG; Wang, ZQ | 1 |
| Chee, E; Looi, A | 1 |
| Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S | 1 |
| Hong, JW; Hu, CQ | 1 |
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Bhagan-Bruno, S; Fergus, IV; Lather, N | 1 |
| Cohen, MB; Govindaraj, S; Hekiert, AM; Montone, KT; Palmer, JN | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Chamberlain, NR; Nguyen, VL; Shapiro, JA | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Garg, B; Kumar, V; Madan, M; Malhotra, R | 1 |
| Ergun, H; Köseoglu-Eser, O; Mamuk, S; Melli, M; Saribas, Z | 1 |
| Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
| Hsueh, PR; Ko, WC; Liao, CH; Lu, JJ | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Artunduaga, JJ; Herrera, MT; Ortiz, CC; Torres, RG | 1 |
| Qu, Y; Wang, Y; Xu, L; Xu, X; Yuan, G; Zhou, M | 1 |
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Fazeli, MR; Sepahi, AA; Shariatmadari, F; Zamani, N | 1 |
4 review(s) available for ofloxacin and vancomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Pseudomembraneous colitis following antibiotic administration--a diagnostic and therapeutic challenge].
Topics: Aged; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Female; Humans; Intestinal Mucosa; Middle Aged; Ofloxacin; Oxazines; Vancomycin | 1988 |
Drug dosing considerations in alternative hemodialysis.
Topics: Anti-Infective Agents, Urinary; Blood Urea Nitrogen; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gentamicins; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Monte Carlo Method; Ofloxacin; Renal Dialysis; Risk Factors; Treatment Outcome; Vancomycin | 2007 |
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Caspofungin; Ceftazidime; Clindamycin; Echinocandins; Fluconazole; Humans; Leukemia, Hairy Cell; Lipopeptides; Male; Middle Aged; Mouth; Ofloxacin; Pneumonia; Pulmonary Artery; Pulmonary Aspergillosis; Valacyclovir; Valine; Vancomycin | 2010 |
4 trial(s) available for ofloxacin and vancomycin
| Article | Year |
|---|---|
A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Humans; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1991 |
Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacteria; Bacterial Infections; Digestive System; Drug Therapy, Combination; Female; Fungi; Humans; Leukemia; Male; Middle Aged; Nasopharynx; Ofloxacin; Polymyxins; Vancomycin | 1990 |
Bactericidal effect of ofloxacin alone and combined with fosfomycin or vancomycin against Staphylococcus aureus in vitro and in sera from volunteers.
Topics: Adult; Anti-Bacterial Agents; Drug Synergism; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Random Allocation; Staphylococcus aureus; Vancomycin | 1987 |
Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Counseling; Drug Prescriptions; Drug Utilization; Female; Guideline Adherence; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organizational Policy; Vancomycin | 2008 |
121 other study(ies) available for ofloxacin and vancomycin
| Article | Year |
|---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cadmium; Chelating Agents; Disk Diffusion Antimicrobial Tests; Ferrous Compounds; Ligands; Magnetic Resonance Spectroscopy; Metals, Heavy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organomercury Compounds; Organometallic Compounds; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Structure-Activity Relationship; Zinc | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
Topics: Anti-Infective Agents; Bacteria; Disk Diffusion Antimicrobial Tests; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Palladium; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman; Yeasts | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
Topics: Anti-Infective Agents; Aza Compounds; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman | 2009 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Apoptosis; Bacteria; Cattle; Cell Line, Tumor; DNA; Humans; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Yeasts | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells | 2010 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Antibacterial Labdane Diterpenoids from Vitex vestita.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Diterpenes; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Malaysia; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Vitex | 2015 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Structural optimization and antibacterial evaluation of rhodomyrtosone B analogues against MRSA strains.
Topics: | 2018 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Novel benzothiazole‒urea hybrids: Design, synthesis and biological activity as potent anti-bacterial agents against MRSA.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Benzothiazoles; Biofilms; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Urea | 2022 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Effects of vancomycin and ofloxacin on rabbit ERG in vivo.
Topics: Animals; Electroretinography; Fundus Oculi; Injections; Ofloxacin; Oscillometry; Rabbits; Retina; Vancomycin; Vitreous Body | 1991 |
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis.
Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Staphylococcal Infections; Vancomycin | 1990 |
[In vitro antibiotic susceptibility of staphylococci].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Sulbactam; Vancomycin | 1989 |
[Effects of vancomycin and ofloxacin on rabbit ERG in vivo].
Topics: Animals; Electroretinography; Injections; Ofloxacin; Rabbits; Retina; Vancomycin; Vitreous Body | 1989 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Resistance, Microbial; Male; Methicillin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.
Topics: Anti-Bacterial Agents; Bacteriuria; Corynebacterium; Humans; Hydrogen-Ion Concentration; Hydroxamic Acids; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Vancomycin | 1987 |
Influence of antibiotics on intestinal mucin in healthy subjects.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Bacitracin; Clindamycin; Doxycycline; Drug Combinations; Electrophoresis, Agar Gel; Erythromycin; Feces; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Metronidazole; Mucins; Nalidixic Acid; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Comparison of simple methods of methicillin-resistance detection and evaluation of some properties of methicillin-resistant Staphylococcus aureus strains.
Topics: Ciprofloxacin; Cross Infection; Evaluation Studies as Topic; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 1993 |
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.
Topics: Animals; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Guinea Pigs; Male; Ofloxacin; Staphylococcal Infections; Vancomycin; Wound Infection | 1994 |
Development of infection with Streptococcus bovis and Aspergillus sp. in irradiated mice after glycopeptide therapy.
Topics: Animals; Anti-Bacterial Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Female; Gram-Positive Bacteria; Liver; Mice; Mice, Inbred C3H; Ofloxacin; Streptococcal Infections; Streptococcus bovis; Teicoplanin; Vancomycin; Whole-Body Irradiation | 1993 |
Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents.
Topics: Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
Investigation of enantioselective separation of quinolonecarboxylic acids by capillary zone electrophoresis using vancomycin as a chiral selector.
Topics: Anti-Infective Agents; Electrophoresis, Capillary; Fluoroquinolones; Ofloxacin; Quinolones; Stereoisomerism; Vancomycin | 1996 |
Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Molecular Sequence Data; Ofloxacin; Penicillins; Staphylococcus; Streptococcus; Vancomycin | 1996 |
The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Lactams; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Streptococcus; Streptococcus pneumoniae; Time Factors; Vancomycin | 1996 |
Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Blood Platelets; Colony Count, Microbial; Fibrin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Vancomycin | 1996 |
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1997 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Surgical Wound Infection; Thienamycins; Time Factors; Vancomycin | 1997 |
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Topics: Ampicillin; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Sulbactam; Vancomycin | 1997 |
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Drug Therapy, Combination; Humans; Incidence; Leukemia; Neoplasms; Ofloxacin; Penicillin Resistance; Penicillin V; Penicillins; Retrospective Studies; Risk Factors; Streptococcal Infections; Treatment Outcome; Vancomycin | 1997 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis.
Topics: Bacterial Adhesion; Biofilms; Catheters, Indwelling; Cefazolin; Isomerism; Ofloxacin; Staphylococcus epidermidis; Vancomycin | 1998 |
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Vancomycin | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Comparative in vitro activity of vancomycin and levofloxacin in combination with rifampin against planktonic versus sessile cells of Staphylococcus epidermidis.
Topics: Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 2000 |
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cefotaxime; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Sepsis; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Vancomycin | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antigens, Viral; Antiviral Agents; Azithromycin; Biopsy, Needle; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunocompromised Host; Kidney Transplantation; Male; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Rhodococcus; Tomography, X-Ray Computed; Vancomycin | 2001 |
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Oxazolidinones; Polymerase Chain Reaction; Quinolines; Sensitivity and Specificity; Staphylococcus aureus; Teicoplanin; Vancomycin | 2001 |
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Disease Models, Animal; Fluoroquinolones; Foreign-Body Reaction; Guinea Pigs; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2002 |
Uncommon vancomycin-induced side effects.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Eosinophilia; Erythema; Female; Fever; Hip Prosthesis; Humans; Methicillin Resistance; Middle Aged; Neutropenia; Ofloxacin; Prosthesis-Related Infections; Pruritus; Staphylococcus; Syndrome; Vancomycin | 2002 |
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000.
Topics: Africa; Americas; Anti-Bacterial Agents; Asia; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Europe; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Vancomycin | 2002 |
Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Eye Infections, Bacterial; Female; Humans; Incidence; Keratitis; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2002 |
Bilateral methicillin-resistant staphylococcus aureus keratitis in a medical resident following an uneventful bilateral photorefractive keratectomy.
Topics: Adult; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelids; Female; Humans; Internship and Residency; Lasers, Excimer; Methicillin Resistance; Ofloxacin; Photorefractive Keratectomy; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Topics: Acetamides; Animals; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Graft Rejection; Levofloxacin; Linezolid; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Efficacy of vancomycin plus levofloxacin combination therapy for refractory pericarditis due to multiresistant Streptococcus pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Male; Ofloxacin; Pericarditis; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillins; Pennsylvania; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2004 |
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Streptococcus pneumoniae; Vancomycin | 2003 |
In vitro effect of levofloxacin and vancomycin combination against high level aminoglycoside-resistant enterococci.
Topics: Aminoglycosides; beta-Lactam Resistance; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; In Vitro Techniques; Levofloxacin; Ofloxacin; Vancomycin | 2004 |
[Sensitivity of MRSA isolated in our hospital to various antibacterial agents: changes over 5 years].
Topics: Aminoglycosides; Coagulase; Dibekacin; Drug Resistance, Bacterial; Enterotoxins; Humans; Imipenem; Methicillin Resistance; Netilmicin; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
Pharmacist-managed service providing penicillin allergy skin tests.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Drug Hypersensitivity; Education, Pharmacy, Continuing; Hospitals, Teaching; Humans; Iowa; Ofloxacin; Penicillins; Pharmacists; Pharmacy Service, Hospital; Professional Role; Program Development; Records; Skin Tests; Vancomycin | 2004 |
Salvage of a prosthetic knee joint infected with resistant pneumococcus. A case report.
Topics: Aged; Anti-Infective Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Azithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Ofloxacin; Pneumococcal Infections; Prosthesis-Related Infections; Rifampin; Vancomycin | 2004 |
Postoperative Corynebacterium macginleyi endophthalmitis.
Topics: Aged; Aqueous Humor; Bacterial Typing Techniques; Cataract Extraction; Chronic Disease; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gene Amplification; Humans; Lens Implantation, Intraocular; Male; Ofloxacin; Polymerase Chain Reaction; Postoperative Complications; Tobramycin; Vancomycin; Vitreous Body | 2004 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
[Pneumonia by Corynebacterium pseudodiphteriticum: an infection to consider].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Corynebacterium; Corynebacterium Infections; Diabetes Mellitus, Type 1; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intubation, Intratracheal; Male; Multiple Trauma; Ofloxacin; Pneumonia, Bacterial; Prednisone; Pulmonary Disease, Chronic Obstructive; Sjogren's Syndrome; Smoking; Vancomycin | 2006 |
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
Topics: Adult; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Health Personnel; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Photorefractive Keratectomy; Postoperative Complications; Refractive Surgical Procedures; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps; Vancomycin | 2007 |
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin | 2007 |
Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices.
Topics: Adsorption; Anti-Bacterial Agents; Biocompatible Materials; Calcium Phosphates; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Implants; Durapatite; Kinetics; Models, Chemical; Ofloxacin; Polyesters; Polyglycolic Acid; Porosity; Powders; Solubility; Surface Properties; Technology, Pharmaceutical; Temperature; Tetracycline; Vancomycin | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Sternal tuberculosis.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Ofloxacin; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sternum; Thorax; Tomography, X-Ray Computed; Tuberculosis; Vancomycin | 2009 |
Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Female; Levofloxacin; Male; Microbial Sensitivity Tests; Models, Animal; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin; Vitreous Body | 2008 |
Kytococcus schroeteri: a probably underdiagnosed pathogen involved in prosthetic valve endocarditis.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Aortic Valve Insufficiency; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Ofloxacin; Polymerase Chain Reaction; Rifampin; Vancomycin | 2008 |
[A case of phlegmonous gastritis which resolved with medical treatment].
Topics: Aged; Anti-Bacterial Agents; Cellulitis; Drug Therapy, Combination; Female; Gastritis; Humans; Levofloxacin; Male; Ofloxacin; Vancomycin | 2008 |
First report of methicillin-resistant Staphylococcus aureus septic arthritis complicating acupuncture: simple procedure resulting in most devastating outcome.
Topics: Acupuncture Analgesia; Adolescent; Adult; Aged; Arthritis, Infectious; Female; Humans; Knee; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Ofloxacin; Synovitis; Vancomycin | 2009 |
A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A.
Topics: Anti-Bacterial Agents; Cefuroxime; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infant; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Vancomycin | 2008 |
[Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
Topics: Anti-Bacterial Agents; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Tobramycin; Vancomycin | 2009 |
Onodi sinusitis presenting with orbital apex syndrome.
Topics: Abscess; Anti-Bacterial Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Ethmoid Sinusitis; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Ofloxacin; Ophthalmologic Surgical Procedures; Orbital Diseases; Staphylococcal Infections; Staphylococcus aureus; Syndrome; Vancomycin | 2009 |
[Investigation on the chiral recognition site of enantioselective separation of ofloxacin by capillary zone electrophoresis using vancomycin as a chiral selector].
Topics: Anti-Bacterial Agents; Electrophoresis, Capillary; Ofloxacin; Stereoisomerism; Vancomycin | 2009 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Acinetobacter endocarditis presenting as a large right atrial mass: an atypical presentation.
Topics: Acinetobacter Infections; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Cefepime; Cephalosporins; Diagnosis, Differential; Endocarditis, Bacterial; Female; Heart Atria; Humans; Kidney Failure, Chronic; Ofloxacin; Ultrasonography; Vancomycin | 2010 |
Ecthyma gangrenosum mimicking acute invasive fungal sinusitis in an immunocompromised patient.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Diagnosis, Differential; Ecthyma; Humans; Immunocompromised Host; Linezolid; Male; Mycoses; Nasal Mucosa; Ofloxacin; Oxazolidinones; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyoderma Gangrenosum; Risk Factors; Sinusitis; Vancomycin | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Evidence for persisters in Staphylococcus epidermidis RP62a planktonic cultures and biofilms.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Biofilms; Drug Resistance, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Microscopy, Confocal; Ofloxacin; Staphylococcus epidermidis; Surface Properties; Time Factors; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Sacroiliitis caused by Salmonella typhi: a case report.
Topics: Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Diarrhea; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Ofloxacin; Pelvic Bones; Radiography; Sacroiliac Joint; Sacroiliitis; Salmonella typhi; Typhoid Fever; Vancomycin; Young Adult | 2011 |
Critical appraisal of air pouch infection model in rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Exudates and Transudates; Female; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2012 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan.
Topics: Anti-Infective Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Fluoroquinolones; Gemifloxacin; Glycosides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifamycins; Rifaximin; Taiwan; Vancomycin | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
[Synthesis of antibiotic loaded polylactic acid nanoparticles and their antibacterial activity against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Escherichia coli O157; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanoparticles; Ofloxacin; Polyesters; Vancomycin | 2017 |
Synergistic combination of two antimicrobial agents closing each other's mutant selection windows to prevent antimicrobial resistance.
Topics: Anti-Bacterial Agents; Culture Media; Doxycycline; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Ofloxacin; Roxithromycin; Vancomycin | 2018 |
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
A new probiotic Lactobacillus plantarum strain isolated from traditional dairy together with nanochitosan particles shows the synergistic effect on aflatoxin B1 detoxification.
Topics: Aflatoxin B1; Anti-Bacterial Agents; Chitosan; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Lactobacillales; Lactobacillus plantarum; Nalidixic Acid; Neomycin; Ofloxacin; Probiotics; Vancomycin | 2022 |